BNF:

3.1.1.1

Status:

Grey

Decision Date:

September 2010

Comments

GREY:^2,4 Lack of long-term data

Grey Drug Classifications

• 2: Lack of data on safety compared with standard therapy
• 4: Lack of data on cost-effectiveness compared with standard therapy

search again